Biotechnology Bounces Back With 46% Rise in Venture Capital – San Francisco Chronicle
By Dr. Matthew Watson
 Citybizlist (press release) | Biotechnology Bounces Back With 46% Rise in Venture Capital San Francisco Chronicle July 20 (Bloomberg) -- Venture-capital funding in biotechnology companies jumped 46 percent in the second quarter, as investors looked to replenish their portfolios after an increase in acquisitions and initial public offerings. ... Biotech sees jump in VC fundingSan Francisco Business Times (blog) Venture Capital Investments Rise 19% In Q2 2011 To $7.5 Billion In 966 DealsPR Web (press release) Venture capitalists invest $13.75 million in South Carolina in second quarterCharleston Regional Business CNET all 145 news articles » |
Uncategorized
Comments Off on Biotechnology Bounces Back With 46% Rise in Venture Capital – San Francisco Chronicle |
July 24th, 2011
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research